But the glucagon component adds something Mounjaro cannot: increased energy output
Biomarker assessment can provide clinical context for personalizing your dosing timeline with your provider
Studies such as SURPASS 15 and J-mono have demonstrated that tirzepatide is more effective than other therapy alternatives in reducing HbA1C levels [84, 85]
[4] [5] The three primary subcutaneous injection sites used for comparable licensed therapies (such as semaglutide and tirzepatide, as described in their UK Summary of Product Characteristics) are: Abdomen the area around the stomach, avoiding the area immediately around the navel Front (anterolateral) thigh the outer-front portion of the upper thigh Upper arms the outer area of the upper arm, typically requiring assistance from another person for self-administration The abdomen is generally considered the most accessible and commonly used site, as it offers a relatively large surface area of subcutaneous fat and is straightforward to self-administer
[9] In other words, cagrilintide revived a decades-old hormonal axis in a once-weekly, combination-ready form
Suppositories work faster (15-60 minutes) but tablets are more convenient (6-12 hours)